1
/
of
1
Elabscience
SKU:E-AB-F1143C-20Tests
FITC Anti-Human CD34 Antibody[581]
FITC Anti-Human CD34 Antibody[581]
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
The FITC Anti-Human CD34 Antibody[581] is a highly specific and sensitive monoclonal antibody that has been designed for use in the detection and quantification of human CD34 antigen. This antibody is conjugated with fluorescein isothiocyanate (FITC), which allows for easy visualization and analysis of CD34 expression in various cell types.
CD34 is a transmembrane glycoprotein that is expressed on hematopoietic stem cells and endothelial progenitor cells. It plays a crucial role in the regulation of hematopoiesis and angiogenesis, making it an important target for research in the fields of stem cell biology and cancer.
The FITC Anti-Human CD34 Antibody[581] has been extensively validated for use in flow cytometry, immunofluorescence, and immunohistochemistry applications. It has been shown to exhibit high specificity and sensitivity, with minimal cross-reactivity with other antigens.
This antibody is supplied in a convenient format, with a concentration of 0.5 mg/mL. It has been purified using protein A affinity chromatography, ensuring high purity and consistency between batches.
The FITC Anti-Human CD34 Antibody[581] is suitable for use in a wide range of research applications, including the identification and isolation of hematopoietic stem cells, the characterization of endothelial progenitor cells, and the detection of CD34 expression in various cancer types.
Overall, the FITC Anti-Human CD34 Antibody[581] is a reliable and effective tool for researchers studying the role of CD34 in hematopoiesis, angiogenesis, and cancer. Its high specificity and sensitivity make it a valuable addition to any laboratory's toolkit.
CD34 is a transmembrane glycoprotein that is expressed on hematopoietic stem cells and endothelial progenitor cells. It plays a crucial role in the regulation of hematopoiesis and angiogenesis, making it an important target for research in the fields of stem cell biology and cancer.
The FITC Anti-Human CD34 Antibody[581] has been extensively validated for use in flow cytometry, immunofluorescence, and immunohistochemistry applications. It has been shown to exhibit high specificity and sensitivity, with minimal cross-reactivity with other antigens.
This antibody is supplied in a convenient format, with a concentration of 0.5 mg/mL. It has been purified using protein A affinity chromatography, ensuring high purity and consistency between batches.
The FITC Anti-Human CD34 Antibody[581] is suitable for use in a wide range of research applications, including the identification and isolation of hematopoietic stem cells, the characterization of endothelial progenitor cells, and the detection of CD34 expression in various cancer types.
Overall, the FITC Anti-Human CD34 Antibody[581] is a reliable and effective tool for researchers studying the role of CD34 in hematopoiesis, angiogenesis, and cancer. Its high specificity and sensitivity make it a valuable addition to any laboratory's toolkit.
Share
![FITC Anti-Human CD34 Antibody[581]](http://danabiosci.com/cdn/shop/products/Elabscience_logo_90b54397-a450-43ff-85a6-bdd8638186fe.png?v=1706704418&width=1445)